RTW INVESTMENTS, LP Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$574.2B
Holdings
27
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALNYAlnylam Pharmaceuticals Inc | 623,338 | $73.2B | 12.75% | |
| 2 | PTCTPTC Therapeutics Inc | 3,495,143 | $69.9B | 12.18% | |
| 3 | BMYBristol Myers Squibb Co | 827,512 | $52.7B | 9.19% | |
| 4 | RGNXRegenxbio Inc | 1,539,005 | $50.7B | 8.83% | |
| 5 | —Avexis Inc | 467,667 | $45.2B | 7.88% | |
| 6 | —La Jolla Pharmaceutical Co | 1,044,307 | $36.3B | 6.33% | |
| 7 | —Achillion Pharmaceuticals In | 7,839,766 | $35.2B | 6.13% | |
| 8 | I9DNArbutus Biopharma Corp | 5,266,280 | $32.7B | 5.69% | |
| 9 | AGENEURAgenus Inc | 4,218,520 | $18.6B | 3.24% | |
| 10 | —Corium Intl Inc | 1,675,479 | $18.6B | 3.23% | |
| 11 | BCRXBioCryst Pharmaceuticals | 3,324,705 | $17.4B | 3.03% | |
| 12 | —Oxford Immunotec Global PLC | 1,032,370 | $17.3B | 3.02% | |
| 13 | —bluebird bio Inc | 104,078 | $14.3B | 2.49% | |
| 14 | EP3OraSure Technologies Inc | 535,707 | $12.1B | 2.10% | |
| 15 | —Dicerna Pharmaceuticals Inc | 2,078,991 | $12.0B | 2.08% | |
| 16 | TCMDTactile Sys Technology Inc | 353,216 | $10.9B | 1.90% | |
| 17 | —Myokardia Inc | 253,962 | $10.9B | 1.90% | |
| 18 | ATRAGBXAtara Biotherapeutics Inc | 656,018 | $10.9B | 1.89% | |
| 19 | 3M4Masimo Corp | 120,900 | $10.5B | 1.82% | |
| 20 | —Viveve Med Inc | 1,473,028 | $7.7B | 1.34% | |
| 21 | VRAYQViewray Inc | 1,020,462 | $5.9B | 1.02% | |
| 22 | —Spring Bk Pharmaceuticals In | 249,095 | $4.2B | 0.73% | |
| 23 | —Bovie Medical Corp | 1,139,600 | $3.9B | 0.67% | |
| 24 | —Zynerba Pharmaceuticals Inc | 200,000 | $1.7B | 0.29% | |
| 25 | GBTUSDGlobal Blood Therapeutics In | 26,310 | $817.0M | 0.14% | |
| 26 | ARGXargenx SE | 24,906 | $563.0M | 0.10% | |
| 27 | —SENSUS HEATLHCARE INC | 155,000 | $90.0M | 0.02% |